|
Status |
Public on Oct 06, 2016 |
Title |
Pathogenicity of genomic duplications is determined by formation of novel chromatin domains (neo-TADs) |
Organisms |
Homo sapiens; Mus musculus |
Experiment type |
Other Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
27706140 |
|
Submission date |
Feb 19, 2016 |
Last update date |
May 15, 2019 |
Contact name |
Daniel Murad Ibrahim |
E-mail(s) |
ibrahim@molgen.mpg.de, daniel.ibrahim@bih-charite.de
|
Phone |
030 84131516
|
Organization name |
Berlin Institute of Health
|
Department |
Center for Regenerative Therapies
|
Street address |
Augustenburger Platz 1
|
City |
Berlin |
State/province |
Berlin |
ZIP/Postal code |
13353 |
Country |
Germany |
|
|
Platforms (4)
|
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
GPL18460 |
Illumina HiSeq 1500 (Homo sapiens) |
GPL18480 |
Illumina HiSeq 1500 (Mus musculus) |
|
Samples (48)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE78067 |
Pathogenicity of genomic duplications is determined by formation of novel chromatin domains (neo-TADs) (4C-seq) |
GSE78072 |
Pathogenicity of genomic duplications is determined by formation of novel chromatin domains (neo-TADs) [Hi-C] |
GSE78105 |
Pathogenicity of genomic duplications is determined by formation of novel chromatin domains (neo-TADs) (RNA-seq) |
|
Relations |
BioProject |
PRJNA312621 |